Spider Venom Drug Trial
This is a Australia news story, published by Live Science.
Australia news
For more Australia news, you can click here:
more Australia newsbiology news
For more biology news, you can click here:
more biology newsLive Science news
For more news from Live Science, you can click here:
more news from Live ScienceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
spider venom. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest heart damage news, donor hearts news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
only cardioprotective drugLive Science
•Drug inspired by spider venom aims to reverse heart attack damage
77% Informative
A small protein called Hi1a works by preventing heart tissue from becoming too acidic during a heart attack.
Starting next summer , the team plans to test the safety of the molecule in a clinical trial in Australia .
The aim is that one day it could also be administered by first responders.
VR Score
85
Informative language
87
Neutral language
81
Article tone
semi-formal
Language
English
Language complexity
45
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
9
Source diversity
8
Affiliate links
2